Related Articles
Expression of regulatory factor X1 can predict the prognosis of breast cancer
MZB1 expression indicates poor prognosis in estrogen receptor‑positive breast cancer
Overexpression of Derlin 3 is associated with malignant phenotype of breast cancer cells
Platelet isoform of phosphofructokinase accelerates malignant features in breast cancer
Elevated tumor mutation burden and immunogenic activity in patients with hormone receptor‑negative or human epidermal growth factor receptor 2‑positive breast cancer